Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Experts call for closer wildlife monitoring to prevent future pandemics
Closer wildlife monitoring of wildlife is required to prevent future pandemics, a group of wildlife experts has warned.

Scientists recommend increase in laboratory testing closer to areas of risk.

Closer monitoring of wildlife is required to prevent future pandemics such as COVID-19 from occurring, a group of wildlife experts has warned.

Writing in the journal Science, experts from the Wildlife Disease Surveillance Focus Group set out several recommendations for improving how wildlife can be better tested and tracked.

The group, which includes researchers from the University of Edinburgh, calls for an increase in laboratory testing capacity at or near locations where humans and wildlife interact. Currently, 62 per cent of laboratories that screen for animal pathogens are located in North America and Europe, which does not reflect the areas at most risk of emerging diseases,the researchers said.

The group also notes that improvements in testing technology could help decentralize testing capacity, for example by using portable DNA sequencing technology.
Such technology is already being trialled at the University of Edinburgh, in partnership with the governments of Zambia and Malaysia, in a project led by the TRACE Wildlife Forensics Network.

Furthermore, the group recommends the creation of a central publicly-accessible database for recording the characteristics of animal viruses to help monitor the risk of crossover to humans.
Researchers say this would allow any scientists to see how pathogens are evolving, how common they are worldwide and identify early mitigation measures, including antiviral treatments or vaccines.

“We know that many diseases like COVID19 can cross from animals to humans but we don’t focus enough on the animal side of the human-animal equation,” explained Professor Anna Meredith, chair of zoological and conservation medicine at the Royal (Dick) School of Veterinary Studies.
“Locally-driven surveillance and responses will empower local wildlife and public health professionals to constantly monitor for pathogens at source and improve the likelihood of prevention or early mitigation of future crossover events.” 

 

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.